Skip to main content
. 2021 Jul 21;11:14849. doi: 10.1038/s41598-021-94360-9

Figure 1.

Figure 1

HCT116CD276KO cells form tumor spheroids similar to HCT116WT cells. (A) CD276 expression on HCT116WT and HCT116CD276KO cells was analyzed by flow cytometry after Crispr-Cas9 gene editing. (B) The heat-map shows the differentially regulated genes related to cell adhesion and migration in HCT116CD276KO cells compared to HCT116WT cells according to global transcriptome analysis. The bar shows the fold change (log2) of the ratio from tpm values (transcripts per kilobase million) of genes in HCT116CD276KO cells to genes in HCT116CD276WT cells. (C) Tumor spheroids formed from HCT116WT and HCT116CD276KO cells were monitored up to 12 days for shape. Representative microscope images are from 9-day and 12-day culture. (D) Quantification of viable tumor cells per spheroid was assessed by flow cytometry. 5–10 spheroids were pooled into a single sample for each group and before dissociation a defined number of negative compensation flow cytometry beads were added. Ratio of recorded bead count to the initial bead amount was used to back calculate viable tumor cells. The graph summarizes data (Mean + SD) from three independent experiments. (E) WST-1 viability assay treatment of spheroids over time. Each dot is one spheroid.